Market Trends AstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy ambition (AZN:NASDAQ)By admin8996erT0allMarch 17, 2025 Roland MagnussonEsoBiotec SA has entered into a definitive agreement to be acquired by AstraZeneca (NASDAQ:AZN) for up to $1 billion,…
Market Trends AstraZeneca’s metastatic breast cancer treatment gets EU recommendation (AZN:NASDAQ)By admin8996erT0allFebruary 28, 2025 koto_fejaAstraZeneca (NASDAQ:AZN) and Daiichi Sankyo said on Friday that the European Medicines Agency (EMA) endorsed ENHERTU for the treatment of…
Market Trends AstraZeneca’s Enhertu gets additional FDA approval (AZN:NASDAQ)By admin8996erT0allJanuary 27, 2025 WirestockAstraZeneca (NASDAQ:AZN) and Daiichi Sankyo’s (OTCPK:DSKYF) drug Enhertu has been approved by the FDA for the treatment of certain breast…
Market Trends AstraZeneca pulls EU filing for lung cancer drug (AZN:NASDAQ)By admin8996erT0allDecember 24, 2024 koto_fejaAstraZeneca (NASDAQ:AZN) and Daiichi Sankyo (OTCPK:DSKYF) announced Tuesday they have withdrawn the EU marketing application for their experimental lung cancer…
